Previous studies have indicated that CHD1 supports tumor growth by modulating metabolic genes such as HK2 and LDHA, with its inhibition suppressing proliferation and inducing apoptosis, particularly in PTEN-deficient models [43]. The gene discussed is HK2; the disease is neoplasm.